HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marat V Ezhov Selected Research

Marat V Ezhov Research Topics

Disease

12Atherosclerosis
01/2024 - 08/2014
9Cardiovascular Diseases (Cardiovascular Disease)
01/2024 - 03/2015
8Coronary Disease (Coronary Heart Disease)
10/2023 - 10/2003
7Coronary Artery Disease (Coronary Atherosclerosis)
06/2023 - 06/2009
6Myocardial Infarction
12/2022 - 10/2003
4Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
01/2024 - 10/2018
3Inflammation (Inflammations)
01/2024 - 01/2021
3Hypertension (High Blood Pressure)
11/2023 - 10/2003
2Hypercholesterolemia
11/2023 - 05/2020
2Atherosclerotic Plaque (Atheroma)
10/2023 - 06/2009
2Dyslipidemias (Dyslipidemia)
10/2023 - 01/2019
2Hypertriglyceridemia
10/2023 - 01/2022
2Aortic Valve Stenosis (Aortic Stenosis)
03/2023 - 01/2020
2Stroke (Strokes)
11/2022 - 01/2019
2Hyperlipoproteinemias
10/2020 - 01/2020
2Chest Pain (Chest Pains)
11/2017 - 10/2003
2Hyperlipidemias (Hyperlipidemia)
11/2017 - 01/2013
2Skeletal Abnormalities Mandibular Hypoplasia Auditory Canal Atresia Short Stature
06/2015 - 03/2015
1Metabolic Syndrome (Dysmetabolic Syndrome X)
10/2023
1Ischemic Stroke
12/2022
1Calcinosis
11/2022
1Peripheral Arterial Disease
05/2020
1Type 2 Diabetes Mellitus (MODY)
01/2019
1Myocardial Ischemia (Ischemic Heart Diseases)
10/2018
1Carotid Artery Diseases
01/2016
1Acute Coronary Syndrome
06/2015
1Pathologic Constriction (Stenosis)
01/2013

Drug/Important Bio-Agent (IBA)

15Lipoprotein(a)IBA
10/2023 - 01/2013
8Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
11/2023 - 01/2013
7oxidized low density lipoproteinIBA
06/2023 - 01/2013
5LipidsIBA
11/2023 - 10/2003
5LDL CholesterolIBA
03/2022 - 11/2017
4Apolipoproteins AIBA
10/2023 - 08/2014
4evolocumabIBA
10/2020 - 01/2019
3CholesterolIBA
01/2024 - 10/2018
3Proprotein Convertase 9IBA
10/2023 - 10/2018
3omega-Chloroacetophenone (Mace)IBA
12/2022 - 02/2022
2Triglycerides (Triacylglycerol)IBA
10/2023 - 01/2019
2AutoantibodiesIBA
03/2023 - 01/2021
2LDL Lipoproteins (beta Lipoproteins)IBA
12/2022 - 10/2018
2Apoprotein(a) (Apolipoprotein (a))IBA
01/2022 - 10/2018
2Lipoproteins (Lipoprotein)IBA
11/2017 - 01/2013
2Atorvastatin (Lipitor)FDA Link
11/2017 - 01/2013
2Complement System Proteins (Complement)IBA
06/2015 - 03/2015
1LDL Receptors (LDL Receptor)IBA
01/2024
1Ezetimibe (Zetia)FDA Link
11/2023
1Fenofibrate (CiL)FDA LinkGeneric
10/2023
1Immunoglobulin M (IgM)IBA
03/2023
1Apolipoprotein C-II (ApoC2)IBA
01/2022
1Antigen-Antibody Complex (Immune Complex)IBA
01/2021
1C-Reactive ProteinIBA
01/2021
1Monoclonal AntibodiesIBA
10/2020
1HDL CholesterolIBA
01/2019
1Insulin (Novolin)FDA Link
01/2019
1PPAR alphaIBA
01/2019
1AN 12IBA
11/2017
1Rosuvastatin Calcium (Crestor)FDA Link
06/2009
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
06/2009
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2009
1ApolipoproteinsIBA
10/2003

Therapy/Procedure

6Blood Component Removal (Apheresis)
01/2020 - 01/2013
3Coronary Artery Bypass (Coronary Artery Bypass Surgery)
11/2022 - 01/2013
3Percutaneous Coronary Intervention
11/2022 - 06/2009
3Therapeutics
01/2020 - 06/2009
2Myocardial Revascularization
06/2009 - 10/2003